189 related articles for article (PubMed ID: 19533181)
1. Diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.
Iizuka Y; Iizuka H; Tsutsumi S; Nakagawa Y; Nakajima T; Sorimachi Y; Ara T; Nishinome M; Seki T; Takagishi K
Eur Spine J; 2009 Oct; 18(10):1431-5. PubMed ID: 19533181
[TBL] [Abstract][Full Text] [Related]
2. Investigations for bone metastasis from an unknown primary.
Destombe C; Botton E; Le Gal G; Roudaut A; Jousse-Joulin S; Devauchelle-Pensec V; Saraux A
Joint Bone Spine; 2007 Jan; 74(1):85-9. PubMed ID: 17218141
[TBL] [Abstract][Full Text] [Related]
3. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach.
Schiff D; O'Neill BP; Suman VJ
Neurology; 1997 Aug; 49(2):452-6. PubMed ID: 9270576
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies.
Werner MK; Aschoff P; Reimold M; Pfannenberg C
Br J Radiol; 2011 Mar; 84(999):e65-7. PubMed ID: 21325361
[TBL] [Abstract][Full Text] [Related]
5. Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary?
Lawrenz JM; Gordon J; George J; Haben C; Rubin BP; Ilaslan H; Mesko NW; Nystrom LM
Clin Orthop Relat Res; 2020 Nov; 478(11):2451-2457. PubMed ID: 33112582
[TBL] [Abstract][Full Text] [Related]
6. Determining the site of the primary cancer in patients with skeletal metastasis of unknown origin: a retrospective study.
Katagiri H; Takahashi M; Inagaki J; Sugiura H; Ito S; Iwata H
Cancer; 1999 Aug; 86(3):533-7. PubMed ID: 10430264
[TBL] [Abstract][Full Text] [Related]
7. [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site].
Pejcić I; Vrbić S; Filipović S; Sćekić M; Petković I; Pejcić L; Djenić N
Vojnosanit Pregl; 2010 Sep; 67(9):723-31. PubMed ID: 20954411
[TBL] [Abstract][Full Text] [Related]
8. CT-guided core-needle biopsy in omental pathology.
Pombo F; Rodriguez E; Martin R; Lago M
Acta Radiol; 1997 Nov; 38(6):978-81. PubMed ID: 9394652
[TBL] [Abstract][Full Text] [Related]
9. Value of CT-guided Core Needle Biopsy in Diagnosing Spinal Lesions: A Comparison Study.
Liang Y; Liu P; Jiang LB; Wang HL; Hu AN; Zhou XG; Li XL; Lin H; Wu D; Dong J
Orthop Surg; 2019 Feb; 11(1):60-65. PubMed ID: 30767427
[TBL] [Abstract][Full Text] [Related]
10. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
11. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site.
Brown RW; Campagna LB; Dunn JK; Cagle PT
Am J Clin Pathol; 1997 Jan; 107(1):12-9. PubMed ID: 8980361
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of metastatic neoplasms with unknown primary.
Bochtler T; Löffler H; Krämer A
Semin Diagn Pathol; 2018 May; 35(3):199-206. PubMed ID: 29203116
[TBL] [Abstract][Full Text] [Related]
14. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy.
Rougraff BT; Kneisl JS; Simon MA
J Bone Joint Surg Am; 1993 Sep; 75(9):1276-81. PubMed ID: 8408149
[TBL] [Abstract][Full Text] [Related]
15. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
Kaya AO; Coskun U; Unlu M; Akdemir UO; Ozdemir NY; Zengin N; Benekli M; Yildiz R; Yaman E; Ozturk B; Gumus M; Uner A; Yamac D; Ucgul E; Buyukberber S
Asian Pac J Cancer Prev; 2008; 9(4):683-6. PubMed ID: 19256759
[TBL] [Abstract][Full Text] [Related]
16. [Metastatic cáncer presentation. Validation of a diagnostic algorithm with 221 consecutive patients].
Losa Gaspà F; Germá JR; Albareda JM; Fernández-Ortega A; Sanjosé S; Fernández Trigo V
Rev Clin Esp; 2002 Jun; 202(6):313-9. PubMed ID: 12093395
[TBL] [Abstract][Full Text] [Related]
17. [The role of PET-CT in detecting unknown primary tumour in patients with cervical lymph node metastases].
Fülöp M; Kásler M; Remenár E; Lengyel Z; Borbély K
Magy Onkol; 2012 May; 56(2):84-92. PubMed ID: 22629545
[TBL] [Abstract][Full Text] [Related]
18. Skeletal metastases of unknown origin: a retrospective analysis of 29 cases.
Jacobsen S; Stephensen SL; Paaske BP; Lie PG; Lausten GS
Acta Orthop Belg; 1997 Mar; 63(1):15-22. PubMed ID: 9151454
[TBL] [Abstract][Full Text] [Related]
19. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
